| Dr Amita Shimpi Bhalla, MD | |
|
5413 Crenshaw Rd, Suite 400, Pasadena, TX 77505-3143 | |
| (713) 943-2800 | |
| (713) 943-2801 |
| Full Name | Dr Amita Shimpi Bhalla |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 26 Years |
| Location | 5413 Crenshaw Rd, Pasadena, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043252448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RS0012X | Internal Medicine - Sleep Medicine | M3388 (Texas) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | M3388 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Karan S Bhalla Md Pllc | 1557525516 | 7 |
News Archive
EPIRUS Biopharmaceuticals, Inc., formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade in a single dose comparator trial.
Ninety percent of cancer deaths resulted from metastasis, the spread of cancer to different areas in the body, yet scientific exploration of the possible mechanical factors that promote metastasis has been limited.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg.
A recent study led by Dr. Parviez Hosseini, a senior research fellow from EcoHealth Alliance (formerly Wildlife Trust), explains the importance of identifying global pandemic risk factors as early as possible, in order to predict the spread of diseases like H1N1 "swine" flu and SARS. "Predictive Power of Air Travel and Socio-Economic data for Early Pandemic Spread," recently published in the scientific publication PLoS ONE, examines the interplay among travel, trade, and national healthcare resources in predicting the emergence and spread of H1N1 and other viruses.
› Verified 1 days ago
| Entity Name | Karan S Bhalla Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427317577 PECOS PAC ID: 1557525516 Enrollment ID: O20120604000507 |
News Archive
EPIRUS Biopharmaceuticals, Inc., formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade in a single dose comparator trial.
Ninety percent of cancer deaths resulted from metastasis, the spread of cancer to different areas in the body, yet scientific exploration of the possible mechanical factors that promote metastasis has been limited.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg.
A recent study led by Dr. Parviez Hosseini, a senior research fellow from EcoHealth Alliance (formerly Wildlife Trust), explains the importance of identifying global pandemic risk factors as early as possible, in order to predict the spread of diseases like H1N1 "swine" flu and SARS. "Predictive Power of Air Travel and Socio-Economic data for Early Pandemic Spread," recently published in the scientific publication PLoS ONE, examines the interplay among travel, trade, and national healthcare resources in predicting the emergence and spread of H1N1 and other viruses.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amita Shimpi Bhalla, MD 5413 Crenshaw Road, Suite 400, Pasadena, TX 77505-3143 Ph: (713) 943-2800 | Dr Amita Shimpi Bhalla, MD 5413 Crenshaw Rd, Suite 400, Pasadena, TX 77505-3143 Ph: (713) 943-2800 |
News Archive
EPIRUS Biopharmaceuticals, Inc., formerly known as fourteen22 Inc, announced that its lead asset, BOW-015, achieved bioequivalence to Remicade in a single dose comparator trial.
Ninety percent of cancer deaths resulted from metastasis, the spread of cancer to different areas in the body, yet scientific exploration of the possible mechanical factors that promote metastasis has been limited.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Alfuzosin Hydrochloride Extended-release Tablets, 10 mg.
A recent study led by Dr. Parviez Hosseini, a senior research fellow from EcoHealth Alliance (formerly Wildlife Trust), explains the importance of identifying global pandemic risk factors as early as possible, in order to predict the spread of diseases like H1N1 "swine" flu and SARS. "Predictive Power of Air Travel and Socio-Economic data for Early Pandemic Spread," recently published in the scientific publication PLoS ONE, examines the interplay among travel, trade, and national healthcare resources in predicting the emergence and spread of H1N1 and other viruses.
› Verified 1 days ago
Dr. Kenneth Ray Vanowen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4141 Vista Rd, Pasadena, TX 77504 Phone: 713-947-3100 | |
Dr. Darel A Butler, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4141 Vista Rd, Pasadena, TX 77504 Phone: 713-947-3100 Fax: 713-947-6103 | |
Kavitha Marri, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3925 Fairmont Parkway, Pediatric & Adolescent Health Center-pasadena, Pasadena, TX 77504 Phone: 713-873-6300 Fax: 281-487-0196 | |
Dr. Robert W. Fayle, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4141 Vista Rd, Pasadena, TX 77504 Phone: 713-947-3100 Fax: 713-947-6103 | |
Dr. Priti Palvadi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4141 Vista Rd, Pasadena, TX 77504 Phone: 713-947-3100 Fax: 713-947-6103 |